The emergence and clinical relevance of EVH, which is typically inconspicuous in untreated PNH patients, may be viewed as an unintended mechanistic consequence of C5 inhibition [15,16]. The gene discussed is C5; the disease is paroxysmal nocturnal hemoglobinuria.